Product Description

Empamac Met is a dual-action oral anti-diabetic tablet combining empagliflozin (SGLT2 inhibitor) and metformin hydrochloride. It helps lower blood sugar in adults with type 2 diabetes when used alongside diet and exercise. Prescription only.

Product Uses (Indications)

• 
  

  For adults (18+) with type 2 diabetes whose blood glucose is not adequately controlled on metformin alone or with other anti-diabetic medicines.

  
  


• 
  

  May be used in combination with other agents, including insulin, as prescribed.

  
  


• 
  

  Can be used as a replacement for separate empagliflozin + metformin tablets to reduce pill burden (do not continue the single tablets in addition to Empamac Met).

  
  

Side Effects

Seek urgent care for:

• 
  

  Lactic acidosis (very rare): vomiting, abdominal pain, severe tiredness, trouble breathing, low body temperature/slow heartbeat.

  
  


• 
  

  Diabetic ketoacidosis (rare): rapid weight loss, nausea/vomiting, stomach pain, deep/fast breathing, confusion, unusual sleepiness, fruity breath or metallic taste—can occur even if glucose isn’t very high.

  
  

Other possible side effects:

• 
  

  Very common: nausea, vomiting, diarrhea, stomach pain, loss of appetite.

  
  


• 
  

  Common: genital yeast infection, passing urine more often, itching, rash/red skin, taste changes, thirst, constipation, ↑ blood lipids (cholesterol).

  
  


• 
  

  Uncommon: hives, pain/straining when urinating, decreases in kidney function (labs), ↑ haematocrit.

  
  


• 
  

  Rare: Fournier’s gangrene (serious infection of genital/perineal area).

  
  


• 
  

  Very rare: ↓ vitamin B12, abnormal liver tests/hepatitis, kidney inflammation.

  
  

How to Use (Dosage & Administration)

• 
  

  Usual dose: 1 tablet twice daily with meals.

  
  


• 
  

  Swallow whole with water.

  
  


• 
  

  Your doctor will select the strength to match your current metformin dose and may adjust for kidney function.

  
  


• 
  

  Missed dose: take when remembered unless near the next dose—do not double.

  
  


• 
  

  Do not stop treatment without medical advice.

  
  

Cautions & Warnings

• 
  

  Do not use if allergic to empagliflozin, metformin, or any ingredient; in type 1 diabetes, ketoacidosis, severe kidney impairment, significant liver disease, severe infection, or dehydration; pregnancy or breastfeeding.

  
  


• 
  

  Surgery/iodinated contrast scans: you may need to stop temporarily—follow your doctor’s instructions.

  
  


• 
  

  Dehydration risk: illness with vomiting/diarrhea/fever, diuretics, low fluid intake, heat exposure—pause and call your doctor.

  
  


• 
  

  With insulin or sulfonylureas: risk of hypoglycaemia—dose adjustments may be needed.

  
  


• 
  

  Alcohol: avoid excessive intake (raises lactic acidosis risk).

  
  


• 
  

  Not recommended to start at ≥85 years; not studied in <18 years.

  
  


• 
  

  Your urine may test positive for glucose while on treatment.

  
  

Active ingredients (per film-coated tablet 12.5/1000 mg):

• 
  

  Empagliflozin 12.5 mg

  
  


• 
  

  Metformin hydrochloride 1000 mg